-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA GRANTS ACCELERATED APPROVAL TO IBERDOMIDE WITH DARATUMUMAB AND HYALURONIDASE-FIHJ AND DEXAMETHASONE FOR MULTIPLE MYELOMA

Reuters·08/13/2026 20:11:26

Please log in to view news